Recommendations for recognizing and diagnosing Acute Hepatic Porphyria in atypical patient populations
2024

Recognizing and Diagnosing Acute Hepatic Porphyria

Sample size: 45 publication Evidence: moderate

Author Information

Author(s): Schmolly Katharina, Rudrapatna Vivek, Beaven Simon

Primary Institution: University of California Los Angeles

Hypothesis

The study investigates the phenotypic and demographic patterns in Acute Hepatic Porphyria patients to update recommendations for recognition and diagnosis.

Conclusion

Patients with a history of OBGYN and psychiatric disorders may be at increased risk of having Acute Hepatic Porphyria.

Supporting Evidence

  • 27 patients tested positive for AHP through urinary metabolites and confirmatory genetic testing.
  • 18 patients tested negative, with 16 receiving a definite alternative diagnosis.
  • Hashimoto’s, Type 1 Diabetes Mellitus, Fibromyalgia, and cannabinoid use were negatively correlated with AHP.
  • Psychiatric disorders and OBGYN disorders were positively correlated with AHP.
  • The highest rate of diagnosis resulted from a combination of genetic and biochemical testing.
  • Testing outside of an acute attack was not associated with a positive diagnosis.

Takeaway

Some people with certain health issues might have a rare disease called Acute Hepatic Porphyria, but doctors often miss it.

Methodology

A retrospective chart analysis was conducted on 45 patients evaluated for AHP, using Electronic Medical Record data.

Potential Biases

Potential under-recognition of AHP due to lack of involvement from certain specialties.

Limitations

There is a lack of studies investigating AHP in non-white populations.

Participant Demographics

Patients evaluated at a tertiary care center, with a focus on demographic patterns.

Digital Object Identifier (DOI)

10.21203/rs.3.rs-4244361

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication